• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number UNK SUPERA
Device Problems Difficult to Remove (1528); Stretched (1601); Difficult or Delayed Activation (2577); Defective Device (2588); Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/11/2023
Event Type  Injury  
Event Description
It was reported that the procedure was to treat a heavily calcified superficial femoral artery and was pre-dilatated with an unspecified balloon.The supera was advanced and during deployment once almost complete the stent crimped up.An unspecified balloon was attempted to advanced; however, could not get through the supera stent.Cut down was performed to remove the stent was explanted and a new supera was used to re-stent.There was no adverse patient sequela and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.D4: the udi is unknown due to the part/lot number was not provided.
 
Event Description
Subsequent to the previously filed report, the following information was provided: it was noted that a 6x120mm supera did not crimp up during deployment.The stent was fully deployed and elongated.Wire access was lost an attempt to rewire was performed; however, the wire became stuck between the stent struts.Unspecified balloon was also attempted to advance, but also got stuck with the stent.Therefore, surgical intervention was required.User facility medwatch report received that states "procedure: open exploration of right distal sfa-p1 with removal of supera stent and coronary balloon percutaneous balloon angioplasty and stent reconstruction of right popliteal and distal sfa percutaneous balloon angioplasty and stenting of prox p2+p1 + distal sfa with 6 mm balloon removal of existing left 6f sheath - closure with celt device md attempted recanalization of long segment right sfa-pop occlusion.During this process, md successfully achieved traversal of occlusion of the common peroneal artery and established continuous flow to the posterior tibial artery.But, with use of the supera stent system in the popliteal and distal sfa position, md's balloon became entrapped in the supera stent.This could not be resolved.Hence, patient comes now to the operating room for removal of the intravascular foreign bodies, and completion of the recanalization procedure if possible.".
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record and similar incident review of the reported lot could not be conducted because the part and lot number was not provided.As there was no reported damage noted to the device during the inspection prior to use, it is possible that interaction with the extremely calcified anatomy resulted in the reported difficult or delayed activation; however this cannot be confirmed.Additionally, it is possible that interaction with the extremely calcified anatomy and/or interaction with the deployed stent as the guidewire was attempted to be advanced resulted in the reported difficult to advance, the reported difficult to remove and ultimately resulted in the reported stretched stent; however this cannot be confirmed.The investigation determined a conclusive cause for the reported difficulties cannot be determined.The treatment appears to be related to the operational context of the procedure a reportedly a cut down was performed to remove the stent and a new supera was used to re-stent.There is no indication of a product quality issue with respect to manufacture, design or labeling.B5 - describe event or problem: updated.D9, h3 - device returning updated from yes to no.H6 - code 2588 was removed and code 1601, 1528 were added.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17645895
MDR Text Key322218632
Report Number2024168-2023-09443
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/29/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK SUPERA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/23/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-